405 related articles for article (PubMed ID: 30128046)
1. Flufenamic acid inhibits secondary hemorrhage and BSCB disruption after spinal cord injury.
Yao Y; Xu J; Yu T; Chen Z; Xiao Z; Wang J; Hu Y; Wu Y; Zhu D
Theranostics; 2018; 8(15):4181-4198. PubMed ID: 30128046
[TBL] [Abstract][Full Text] [Related]
2. Ghrelin inhibits BSCB disruption/hemorrhage by attenuating MMP-9 and SUR1/TrpM4 expression and activation after spinal cord injury.
Lee JY; Choi HY; Na WH; Ju BG; Yune TY
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2403-12. PubMed ID: 25261791
[TBL] [Abstract][Full Text] [Related]
3. Mithramycin A Improves Functional Recovery by Inhibiting BSCB Disruption and Hemorrhage after Spinal Cord Injury.
Lee JY; Choi HY; Park CS; Ju BG; Yune TY
J Neurotrauma; 2018 Feb; 35(3):508-520. PubMed ID: 29048243
[TBL] [Abstract][Full Text] [Related]
4. 17β-estradiol inhibits MMP-9 and SUR1/TrpM4 expression and activation and thereby attenuates BSCB disruption/hemorrhage after spinal cord injury in male rats.
Lee JY; Choi HY; Na WH; Ju BG; Yune TY
Endocrinology; 2015 May; 156(5):1838-50. PubMed ID: 25763638
[TBL] [Abstract][Full Text] [Related]
5. Protocatechuic acid improves functional recovery after spinal cord injury by attenuating blood-spinal cord barrier disruption and hemorrhage in rats.
Park CS; Lee JY; Choi HY; Ju BG; Youn I; Yune TY
Neurochem Int; 2019 Mar; 124():181-192. PubMed ID: 30664898
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury.
Lee JY; Choi HY; Ahn HJ; Ju BG; Yune TY
Am J Pathol; 2014 Nov; 184(11):2985-3000. PubMed ID: 25325922
[TBL] [Abstract][Full Text] [Related]
7. Cordycepin-enriched WIB-801C from Cordyceps militaris improves functional recovery by attenuating blood-spinal cord barrier disruption after spinal cord injury.
Lee JY; Choi HY; Baik HH; Ju BG; Kim WK; Yune TY
J Ethnopharmacol; 2017 May; 203():90-100. PubMed ID: 28363523
[TBL] [Abstract][Full Text] [Related]
8. TRPM7 Mediates BSCB Disruption After Spinal Cord Injury by Regulating the mTOR/JMJD3 Axis in Rats.
Park CS; Lee JY; Seo KJ; Kim IY; Ju BG; Yune TY
Mol Neurobiol; 2024 Feb; 61(2):662-677. PubMed ID: 37653221
[TBL] [Abstract][Full Text] [Related]
9. Water treadmill training attenuates blood-spinal cord barrier disruption in rats by promoting angiogenesis and inhibiting matrix metalloproteinase-2/9 expression following spinal cord injury.
Ying X; Xie Q; Li S; Yu X; Zhou K; Yue J; Chen X; Tu W; Yang G; Jiang S
Fluids Barriers CNS; 2020 Nov; 17(1):70. PubMed ID: 33292360
[TBL] [Abstract][Full Text] [Related]
10. Valproic acid attenuates blood-spinal cord barrier disruption by inhibiting matrix metalloprotease-9 activity and improves functional recovery after spinal cord injury.
Lee JY; Kim HS; Choi HY; Oh TH; Ju BG; Yune TY
J Neurochem; 2012 Jun; 121(5):818-29. PubMed ID: 22409448
[TBL] [Abstract][Full Text] [Related]
11. Gallic acid attenuates blood-spinal cord barrier disruption by inhibiting Jmjd3 expression and activation after spinal cord injury.
Park CS; Lee JY; Choi HY; Lee K; Heo Y; Ju BG; Choo HP; Yune TY
Neurobiol Dis; 2020 Nov; 145():105077. PubMed ID: 32898645
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable bilayer hydrogel membranes loaded with bazedoxifene attenuate blood-spinal cord barrier disruption via the NF-κB pathway after acute spinal cord injury.
Xin W; Baokun Z; Zhiheng C; Qiang S; Erzhu Y; Jianguang X; Xiaofeng L
Acta Biomater; 2023 Mar; 159():140-155. PubMed ID: 36736849
[TBL] [Abstract][Full Text] [Related]
13. Jmjd3 mediates blood-spinal cord barrier disruption after spinal cord injury by regulating MMP-3 and MMP-9 expressions.
Lee JY; Na WH; Choi HY; Lee KH; Ju BG; Yune TY
Neurobiol Dis; 2016 Nov; 95():66-81. PubMed ID: 27425890
[TBL] [Abstract][Full Text] [Related]
14. Dl-3-n-butylphthalide Attenuates Spinal Cord Injury via Regulation of MMPs and Junction Proteins in Mice.
Zheng B; Jin Y; Mi S; Xu W; Yang X; Hong Z; Wang Z
Neurochem Res; 2021 Sep; 46(9):2297-2306. PubMed ID: 34086144
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine and vitamin C synergistically inhibits blood-spinal cord barrier disruption and improves functional recovery after spinal cord injury.
Lee JY; Choi HY; Yune TY
Neuropharmacology; 2016 Oct; 109():78-87. PubMed ID: 27256500
[TBL] [Abstract][Full Text] [Related]
16. Engaging pain fibers after a spinal cord injury fosters hemorrhage and expands the area of secondary injury.
Turtle JD; Henwood MK; Strain MM; Huang YJ; Miranda RC; Grau JW
Exp Neurol; 2019 Jan; 311():115-124. PubMed ID: 30268767
[TBL] [Abstract][Full Text] [Related]
17. Flufenamic acid improves survival and neurologic outcome after successful cardiopulmonary resuscitation in mice.
Chen J; Chang Y; Zhu J; Peng Y; Li Z; Zhang K; Zhang Y; Lin C; Lin Z; Pan S; Huang K
J Neuroinflammation; 2022 Sep; 19(1):214. PubMed ID: 36050694
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine inhibits matrix metalloprotease activation and prevents disruption of blood-spinal cord barrier after spinal cord injury.
Lee JY; Kim HS; Choi HY; Oh TH; Yune TY
Brain; 2012 Aug; 135(Pt 8):2375-89. PubMed ID: 22798270
[TBL] [Abstract][Full Text] [Related]
19. Matrix Metalloproteinase-8 Inhibition Prevents Disruption of Blood-Spinal Cord Barrier and Attenuates Inflammation in Rat Model of Spinal Cord Injury.
Kumar H; Jo MJ; Choi H; Muttigi MS; Shon S; Kim BJ; Lee SH; Han IB
Mol Neurobiol; 2018 Mar; 55(3):2577-2590. PubMed ID: 28421532
[TBL] [Abstract][Full Text] [Related]
20. Suppression of Transient Receptor Potential Melastatin 7 by Carvacrol Protects against Injured Spinal Cord by Inhibiting Blood-Spinal Cord Barrier Disruption.
Park CS; Lee JY; Choi HY; Yune TY
J Neurotrauma; 2022 May; 39(9-10):735-749. PubMed ID: 35171694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
